Shruti M. Chaturvedi

Shruti M. Chaturvedi

Hematology | Oncology

300 Mason Lord Drive
Kimmel Cancer Center
Baltimore, MD 21224

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Exploratory research in immune TTP and other ultra-rare diseases-Balancing statistical idealism with pragmatic discovery.

Exploratory research in immune TTP and other ultra-rare diseases-Balancing statistical idealism with pragmatic discovery.

Journal: British journal of haematology

Published: May 19, 2026

Clinical predictors of mortality in immune thrombotic thrombocytopenic purpura: A National Inpatient Sample analysis.

Clinical predictors of mortality in immune thrombotic thrombocytopenic purpura: A National Inpatient Sample analysis.

Journal: British journal of haematology

Published: April 15, 2026

Clinical predictors of mortality in immune thrombotic thrombocytopenic purpura: A National Inpatient Sample analysis.

Clinical predictors of mortality in immune thrombotic thrombocytopenic purpura: A National Inpatient Sample analysis.

Journal: British journal of haematology

Published: April 15, 2026

Hematologic disorders in pregnancy: the role of the complement system.

Hematologic disorders in pregnancy: the role of the complement system.

Journal: Expert review of hematology

Published: March 05, 2026

Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors.

Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors.

Journal: Research and practice in thrombosis and haemostasis

Published: February 04, 2026

Real-World Effectiveness of Ravulizumab Among C5 Inhibitor-Naive Patients With Atypical Hemolytic Uremic Syndrome: A Physician Panel-Based Chart Review (aHUS IMPACT Study).

Real-World Effectiveness of Ravulizumab Among C5 Inhibitor-Naive Patients With Atypical Hemolytic Uremic Syndrome: A Physician Panel-Based Chart Review (aHUS IMPACT Study).

Journal: Kidney medicine

Published: February 03, 2026

Editorial: Antibody-mediated thrombotic disease.

Editorial: Antibody-mediated thrombotic disease.

Journal: Frontiers in immunology

Published: January 30, 2026

Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities.

Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities.

Journal: Blood vessels, thrombosis & hemostasis

Published: January 20, 2026

Cancer-Associated Thrombosis: Surveying Patients' Awareness and Education Needs.

Cancer-Associated Thrombosis: Surveying Patients' Awareness and Education Needs.

Journal: JCO oncology advances

Published: January 07, 2026

The Clinical Respiratory Score: Diagnostic Performance for Acute Chest Syndrome in Sickle Cell Disease.

The Clinical Respiratory Score: Diagnostic Performance for Acute Chest Syndrome in Sickle Cell Disease.

Journal: Pediatric pulmonology

Published: December 26, 2025

Real-world avatrombopag use for immune thrombocytopenia in the United States: the REAL-AVA 2.0 multisite chart review study.

Real-world avatrombopag use for immune thrombocytopenia in the United States: the REAL-AVA 2.0 multisite chart review study.

Journal: Blood vessels, thrombosis & hemostasis

Published: October 15, 2025

Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivors.

Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivors.

Journal: British journal of haematology

Published: August 20, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026